Abstract:
Acute generalized exanthematous pustulosis (AGEP) is an exanthematous condition, predominantly occurs as a result of drug reaction.
We hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19 without hydroxychloroquine use which serves as a reminder for considering remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients.